2m 2m 2m 2m 2m 2m 2m
VTV THERAP-A (VTVT)
NASDAQ
$35.41+$0.08 (+0.23%)
Price as of Jun 23, 2026 4:49 PM EDT- $133.6MMarket Cap
- 123.58%1-Year Change
- BiotechnologyIndustry
VTV THERAP-A (VTVT)
$35.41+$0.08 (+0.23%)
VTVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.33 | ||
Change | +$1.41 (+4.14%) | ||
Open | $33.96 | ||
High | $35.77 | ||
Low | $33.78 | ||
Previous Close | $33.92 | ||
Volume | 41,792 | ||
30-Day Average Volume | 41,191 | ||
1-Week Change | 9.57% | ||
1-Month Change | 2.67% | ||
1-Year Change | 123.58% | ||
3-Year Change | 14.17% | ||
5-Year Change | -64.82% | ||
Fundamentals | |||
Shares Outstanding | 3.9M | ||
Total Assets | $98.8M | ||
Market Cap | $133.6M | ||
Enterprise Value | $35.5M | ||
Period: QTR TTM FY | |||
Revenue | $36.8M | ||
Net Income | $24.1M | ||
Free Cash Flow | $9.2M | ||
EBIT | $24.1M | ||
EBITDA | $24.1M | ||
Net Working Capital | $91.9M | ||
EPS | $1.65 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 1 | ||
P/E | 21 | ||
PEG | 0 | ||
Price/Free Cash Flow | 15 | ||
Price/Operating Cash Flow | 15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 11/21/2023 | ||
Earnings & Revenue